Galena Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 95   

Articles published

GALE 0.450 -0.020 (-4.26%)
price chart
FBR Slashes Price Target For Galena Biopharma Inc (GALE); Reiterates Positive ...
FBR analyst Vernon Bernardino was out today with a mix report on shares of Galena Biopharma Inc (NASDAQ:GALE), reiterating an Outperform rating while slashing the price target to $2.00 (from $5.00), which implies an upside of 327% from current levels.
2 Biotech Stocks News And Price Trends: Galena Biopharma, Inc. (NASDAQ:GALE ...  The Voice Registrar
Analyst Opinion of: Galena Biopharma, Inc. (NASDAQ:GALE)  News Oracle
Galena Biopharma Inc. (GALE) Jumps 27.39% on July 20
Galena Biopharma Inc. (GALE) was among the biggest gainers on the Russell 2000 for Wednesday July 20 as the stock popped 27.39% to $0.49, representing a gain of $0.1044 per share.
Two Biotech Stocks Are Just So Hot Right Now: Galena Biopharma, Inc. (GALE ...
Galena Biopharma, Inc. (GALE) ended last trading session with a change of -3.19 percent. It trades at an average volume of 7.42M shares versus 21.93M shares recorded at the end of last trading session.
Why Galena Biopharma Inc. Is Being Obliterated Today
What: Investors in the small-cap cancer immunotherapy developer Galena Biopharma (NASDAQ:GALE) are having an awful day. The company's share price has utterly collapsed, falling more than 83% as of 10:00 a.m.
FBR Weighs In On Galena Biopharma Inc (GALE) Following Clinical Setback  Smarter Analyst
Form 8-K Galena Biopharma, Inc. For: Jun 27
Is Galena Biopharma Inc (NASDAQ:GALE) Just Down, Or Is It Out?
Few companies in any sector have had as tough a couple of weeks as has Galena Biopharma Inc (NASDAQ:GALE). Between February and June, the company gained from $.65 a share to $2.27 a share, on market expectations of positive interim data from its ...
Summary of Analyst's Study: Galena Biopharma, Inc. (NASDAQ:GALE ...  Street Updates
Galena Biopharma Inc. (GALE) Receives Buy Rating from Maxim Group  The Cerbat Gem
Galena Biopharma Inc. (GALE) Receives "Outperform" Rating from FBR & Co
Galena Biopharma logo Galena Biopharma Inc. (NASDAQ:GALE) had its price target lowered by analysts at FBR & Co from $5.00 to $2.00 in a report released on Friday.
Biotechnology Stocks in the Spotlight: Galena Biopharma Inc (NASDAQ:GALE ...
Galena Biopharma Inc (NASDAQ:GALE) shares went up 27.39% or 0.104 points to reach at $0.486 during the course of session. The stock traded in the range of $0.38 - $0.49 during its most recent trading session.
Galena Biopharma Inc. (GALE) Jumps 33.17% on June 30
Galena Biopharma Inc. (GALE) was among the biggest gainers on the Russell 2000 for Thursday June 30 as the stock popped 33.17% to $0.47, representing a gain of $0.1161 per share.
The Impact Score of Galena Biopharma, Inc. (NASDAQ:GALE) Is 92
Alpha One tracks the most impactfulonline sources that publish content about a particular company on a daily basis. It provides analytics based on the published content.
Galena Biopharma, Inc. Stock Momentum Hits Weakness
This is a momentum stock rating analysis for Galena Biopharma, Inc. (NASDAQ:GALE) . The company has a two bull momentum rating which indicates some weakness.